Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Seung Myung Dong"'
Autor:
Yongjun Cha, Sun Young Kim, Hyun Yang Yeo, Ji Yeon Baek, Moon Ki Choi, Kyung Hae Jung, Seung Myung Dong, Hee Jin Chang
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 1, Pp 146-155 (2019)
Aberrant promoter methylation plays a vital role in colorectal carcinogenesis. However, its role in treatment responses is unclear, especially for metastatic disease. Here, we investigated the association between promoter methylation and treatment ou
Externí odkaz:
https://doaj.org/article/546385eb2f204dfa846e37ca29cc3121
Autor:
Dong Wook Kang, Ju Hee Kim, Kyung Min Kim, Seok-jin Cho, Hee-Woon Jang, Ji Won Chang, Seung Myung Dong, Jee Woong Lim, Jae-Sun Kim, Hea-Young Cho
Publikováno v:
Pharmaceutics, Vol 13, Iss 9, p 1406 (2021)
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a free radical scavenger approved for the treatment of amyotrophic lateral sclerosis, a fatal neuromuscular disease. Edaravone is administered as an intravenous infusion over 60 min for several treat
Externí odkaz:
https://doaj.org/article/a86deb605e67422a85de7ee80122c8e0
Autor:
HYUNG SUN KIM, YUN SUN LEE, SEUNG MYUNG DONG, HYO JUNG KIM, DA EUN LEE, HYEON WOONG KANG, MYEONG JIN KIM, JOON SEONG PARK
Publikováno v:
Oncology Research; 2024, Vol. 32 Issue 4, p615-624, 10p
Autor:
Hyung Sun Kim, Yun Sun Lee, Seung Myung Dong, Hyo Jung Kim, Da Eun Lee, Hyeon Woong Kang, Myeong Jin Kim, Joon Seong Park
BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid malignancies. A specific mechanism of its metastasis is not established. In our present study, we investigated whether Neural Wiskott-Aldrich Syndrome Protein (N-WA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a335863b865ef5b0fc1f5193934f70
https://doi.org/10.21203/rs.3.rs-1992553/v1
https://doi.org/10.21203/rs.3.rs-1992553/v1
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports
Scientific Reports
Specific protein 1 (SP1) is associated with aggressive behavior, invasive clinical phenotype and poor clinical outcomes in various cancers. We studied whether SP1 exerts its effect on invasiveness and promotion of the epithelial-mesenchymal transitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0169e66431fba7781cf3a0474598a6e
http://link.springer.com/article/10.1038/s41598-019-42501-6
http://link.springer.com/article/10.1038/s41598-019-42501-6
Autor:
Hyun Yang Yeo, Kyung Hae Jung, Yongjun Cha, Sun-Young Kim, Moon Ki Choi, Hee Jin Chang, Seung Myung Dong, Ji Yeon Baek
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 1, Pp 146-155 (2019)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Aberrant promoter methylation plays a vital role in colorectal carcinogenesis. However, its role in treatment responses is unclear, especially for metastatic disease. Here, we investigated the association between promoter methylation and treatment ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef1cbf0456599fdf8daa9f9e9cfafef3
http://www.sciencedirect.com/science/article/pii/S147655861830530X
http://www.sciencedirect.com/science/article/pii/S147655861830530X
Autor:
Jae-Sun Kim, Hea-Young Cho, Ji Won Chang, Seung Myung Dong, Jee Woong Lim, Hee-Woon Jang, Ju Hee Kim, Kyungmin Kim, Seok-jin Cho, Dong Wook Kang
Publikováno v:
Pharmaceutics
Pharmaceutics, Vol 13, Iss 1406, p 1406 (2021)
Volume 13
Issue 9
Pharmaceutics, Vol 13, Iss 1406, p 1406 (2021)
Volume 13
Issue 9
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a free radical scavenger approved for the treatment of amyotrophic lateral sclerosis, a fatal neuromuscular disease. Edaravone is administered as an intravenous infusion over 60 min for several treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88830c0527cfd1b36d12bff145d52f7
https://doi.org/10.3390/pharmaceutics13091406
https://doi.org/10.3390/pharmaceutics13091406
Autor:
Ja Seung Koo, Jeon Han Park, Jae Myun Lee, Pil Gu Park, Min Jung Kim, Su Ji Jo, Hye Ran Cha, Seung Myung Dong, Joon Jeong, Sung Gwe Ahn, Hyemi Kim
Publikováno v:
Oncotarget
// Su Ji Jo 1, 2, * , Pil-Gu Park 1, * , Hye-Ran Cha 1 , Sung Gwe Ahn 3 , Min Jung Kim 1 , Hyemi Kim 1, 2 , Ja Seung Koo 4 , Joon Jeong 3 , Jeon Han Park 1 , Seung Myung Dong 5, 6 and Jae Myun Lee 1, 2 1 Department of Microbiology and Immunology, Yon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd806a9ddef020125f9a17f0319a75e
https://doi.org/10.18632/oncotarget.20227
https://doi.org/10.18632/oncotarget.20227
Autor:
Kang Young Lee, Cheol Keun Park, Ji Hae Lee, Hoguen Kim, Jae Myun Lee, Hyunki Kim, Pil Gu Park, Su Ji Jo, Min Jung Kim, Seung Myung Dong, Hyun Jeong Kim, Jeon Han Park
Publikováno v:
Oncotarget
// Pil-Gu Park 1, * , Su Ji Jo 1, 2, * , Min Jung Kim 1, 3 , Hyun Jeong Kim 4 , Ji Hae Lee 5 , Cheol Keun Park 6 , Hyunki Kim 6 , Kang Young Lee 7 , Hoguen Kim 2, 6 , Jeon Han Park 1 , Seung Myung Dong 5, 8 and Jae Myun Lee 1, 2 1 Department of Micro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6933326498f3b1a8257791d2199f69d5
https://doi.org/10.18632/oncotarget.18170
https://doi.org/10.18632/oncotarget.18170
Autor:
Hyemi Kim, Jong Doo Lee, Young Nyun Park, Taekwon Son, Seung Myung Dong, Jeon Han Park, Hyun Gyu Lee, Youngtae Jeong, Jae Myun Lee, Seung Up Kim
Publikováno v:
Oncotarget
// Hyun Gyu Lee 1 , Hyemi Kim 1, 2 , Taekwon Son 3 , Youngtae Jeong 4 , Seung Up Kim 5 , Seung Myung Dong 6 , Young Nyun Park 2, 7 , Jong Doo Lee 8 , Jae Myun Lee 1, 2 , Jeon Han Park 1 1 Department of Microbiology and Immunology, Institute for Immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8b0746ef3410e104bc26b72d639325b
https://doi.org/10.18632/oncotarget.9723
https://doi.org/10.18632/oncotarget.9723